Danuglipron: Developed by Pfizer and intended to keep blood glucose at healthy levels, this oral GLP-1 recently completed Phase 2 clinical trials for the treatment of type 2 diabetes and obesity
IGF-I is a mediator of growth hormone action
Our studies were performed in normal volunteers (ages 3570)
Our providers can diagnose, treat, and follow up with patients, maintaining a strong connection and continuity of care no matter the distance
For instance, studies from Australia revealed that on average, children and young people aged 5-17 years spent one and a half hours (91 minutes) per day on physical activity and over two hours a day (136 minutes) in screen-based activity with physical activity decreasing and screen-based activity increasing as age increased [53]
Clean Peptides: PureRawz sources all of their research chemicals from industry-accredited partners, providing researchers with added peace of mind that their materials are genuine and safe to use in experiments